Amide compound, its preparation method, pharmaceutical composition and application

An amide compound and compound technology, which can be applied in the preparation of organic compounds, drug combination, preparation of carboxylic acid amides, etc., can solve problems such as large side effects and poor blood lipid-lowering drug effect.

Active Publication Date: 2018-05-04
SHANGHAI INST OF PHARMA IND CO LTD +1
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The technical problem to be solved by the present invention is to provide an amide compound, its preparation method, pharmaceutical composition and application in order to overcome the defects of poor effect of existing blood lipid-lowering drugs and large side effects after long-term use.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Amide compound, its preparation method, pharmaceutical composition and application
  • Amide compound, its preparation method, pharmaceutical composition and application
  • Amide compound, its preparation method, pharmaceutical composition and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0177] Embodiment 1: Preparation of amides compound 1-1

[0178] 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionyl chloride 1g, 2-aminoacetophenone 0.4g, triethylamine 0.3g, dichloromethane 60mL in 100mL In a single-necked bottle, react at room temperature for 4 hours, evaporate the solvent to dryness, and obtain 1-11.09 g of the target amide compound by column chromatography, with a yield of 84%. MS (ESI): 436 [M+H + ].

[0179] Amide compounds 1-2 and amide compounds 1-3 can be prepared by a method similar to that described in Example 1 from corresponding raw materials. Amide compound 1-2: MS (ESI): 368[M+H + ]. Amide compounds 1-3: MS (ESI): 479 [M+H + ].

Embodiment 2

[0180] Embodiment 2: the preparation of amides compound 1-1

[0181] 2-methyl-2-(4-(4-chlorobenzoyl)phenoxy)propionic acid 1g, dicyclohexylcarbodiimide 0.57g, 2-aminoacetophenone 0.33g, dichloromethane 60mL Place in a 100mL single-necked bottle, react at room temperature for 4 hours, evaporate the solvent to dryness, and obtain the target amide compound 1-11.12g by column chromatography, with a yield of 82%.

Embodiment 3

[0182] Embodiment 3: the preparation of amides compound 1-4

[0183] 5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoyl chloride 1g, 2-amino-(4-bromophenyl)-ethanone 0.79g, triethylamine 0.38g, 60 mL of dichloromethane was placed in a 100 mL single-necked bottle, reacted at room temperature for 4 hours, the solvent was evaporated to dryness, and column chromatography obtained 1-41.35 g of the target amide compound with a yield of 81%. MS (ESI): 446 [M+H + ].

[0184] Amide compounds 1-5 to amide compounds 1-16 can be prepared by a method similar to that described in Example 3 using corresponding raw materials.

[0185] Amide compound 1-5: Yield 83%, MS (ESI): 386[M+H + ].

[0186] Amide compound 1-6: Yield 87%, MS (ESI): 514[M+H + ].

[0187] Amide compounds 1-7: Yield 79%, MS (ESI): 402[M+H + ].

[0188] Amide compounds 1-8: Yield 76%, MS (ESI): 470[M+H + ].

[0189] Amide compounds 1-9: Yield 82%, MS (ESI): 454[M+H + ].

[0190] Amide compounds 1-10: Yield 85%, MS (ES...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle size (mesh)aaaaaaaaaa
Login to View More

Abstract

The invention discloses amide compounds, their preparation method, pharmaceutical composition and application. The present invention provides an amide compound as shown in formula 1, its pharmaceutically acceptable salt, metabolite, metabolite precursor or drug prodrug thereof. The amide compound of the invention has the effect of reducing blood cholesterol and low-density lipoprotein, and has the effects of promoting bile secretion, reducing the content of cholesterol in bile, increasing the content of bile acid, and preventing and curing cholelithiasis.

Description

technical field [0001] The present invention relates to amide compounds, their preparation method, pharmaceutical composition and application. Background technique [0002] Cardiovascular and cerebrovascular diseases are currently the most serious disease that endangers human life and health, and are common and frequently-occurring diseases among middle-aged and elderly people. It ranks first in morbidity and mortality in many countries. Atherosclerosis is the basis of many cardiovascular and cerebrovascular diseases. A large number of experimental and clinical data prove that atherosclerosis is closely related to abnormal blood lipid metabolism. Therefore, lipid-regulating drugs have become an important field of current drug research. [0003] Through prospective, random and controlled clinical studies, it has been proved that some statins can reduce the occurrence of atherosclerosis and coronary heart disease, reduce the mortality caused by coronary heart disease, and re...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityPatents(China)
IPC IPC(8): C07C231/02C07C235/06A61K31/192A61K31/165A61K31/166A61K31/235A61P3/06A61P1/16
Inventor于振鹏张瑱王国平肖璘刘珉宇潘绵立刘全海
OwnerSHANGHAI INST OF PHARMA IND CO LTD